Beta Bionics, Inc.
BBNX
$10.65
-$0.31-2.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Revenue | 20.44M | 16.71M | 8.35M | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 20.44M | 16.71M | 8.35M | ||
| Cost of Revenue | 8.75M | 7.79M | 3.29M | ||
| Gross Profit | 11.69M | 8.91M | 5.06M | ||
| SG&A Expenses | 15.51M | 14.75M | 8.97M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 33.48M | 27.68M | 16.72M | ||
| Operating Income | -13.04M | -10.98M | -8.37M | ||
| Income Before Tax | -18.11M | -9.74M | -18.85M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -18.11M | -9.74M | -18.85M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -18.11M | -9.74M | -18.85M | ||
| EBIT | -13.04M | -10.98M | -8.37M | ||
| EBITDA | -12.81M | -10.67M | -8.08M | ||
| EPS Basic | -2.72 | -1.55 | -3.13 | ||
| Normalized Basic EPS | -1.70 | -0.97 | -1.95 | ||
| EPS Diluted | -2.72 | -1.55 | -3.13 | ||
| Normalized Diluted EPS | -1.70 | -0.97 | -1.95 | ||
| Average Basic Shares Outstanding | 6.67M | 6.26M | 6.03M | ||
| Average Diluted Shares Outstanding | 6.67M | 6.26M | 6.03M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||